In the NJEM trial, 4-10% of patients in the retatrutide group reported fatigue, while 4% of patients in the placebo group experienced fatigue
Unlike phosphodiesterase-5 (PDE5) inhibitors such as sildenafil or tadalafil, which directly enhance nitric oxide signaling in penile tissue, tirzepatide's primary targets are metabolic receptors in the pancreas, gastrointestinal tract, and brain
The Lancet Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials Qingyang Shi et al.
Who Should Use Liposomal Glutathione
24 MhamdiA.HagerJ.ChaouchS.QuevalG.HanY.TaconnatL.et al
This review aims to synthesize current evidence on GDMT in HFpEF, focusing on clinically relevant pharmacologic interventions and their application in hospitalized patients